Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 72, Issue 8
Volume 72, Issue 8
15 April 2021
ISSN 1058-4838
EISSN 1537-6591

Volume 72, Issue 8, 15 April 2021

IN THE LITERATURE

Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages i–ii, https://doi.org/10.1093/cid/ciab174

MAJOR ARTICLES AND COMMENTARIES

Lauren F Collins and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1301–1311, https://doi.org/10.1093/cid/ciaa204

Women living with HIV (WLWH) experienced a greater burden of non-AIDS comorbidities than HIV-seronegative counterparts overall and in certain age groups. Traditional risk factors were commonly associated with multimorbidity and should be prioritized for screening and intervention in aging WLWH.

Moises A Huaman and Carl J Fichtenbaum
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1312–1313, https://doi.org/10.1093/cid/ciaa209
Abhishek Deshpande and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1314–1322, https://doi.org/10.1093/cid/ciaa212

Less than 15% of eligible patients with pneumonia had antibiotics de-escalated immediately following negative cultures and de-escalation rates varied widely among hospitals. To adhere to newly published guidelines, hospitals will have to change practice substantially.

Elisa Kortela and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1323–1331, https://doi.org/10.1093/cid/ciaa217

In this study, 210 patients with Lyme neuroborreliosis were randomized to receive either ceftriaxone for 3 weeks or doxycycline for 4 weeks. Patients in both groups improved equally as measured by visual analogue scale after 12 months of follow-up.

Thomas M Hooton and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1332–1338, https://doi.org/10.1093/cid/ciaa274

In this observational cohort study in 104 women evaluated daily, Escherichia coli Asymptomatic Bacteriuria (ASB) (≥105 CFU/mL) occurred on 2.5% of days and rarely persisted beyond 2 days. Pyuria occurred on 25% of days but was poorly predictive of E. coli ASB.

Barbara W Trautner
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1339–1341, https://doi.org/10.1093/cid/ciaa280
Debika Bhattacharya and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1342–1349, https://doi.org/10.1093/cid/ciaa244

Severe hepatotoxicity occurred in 2.5% of women with HIV who initiated efavirenz-containing regimens. Liver-related mortality occurred in 3% of those with severe hepatotoxicity. Older age was predictive of severe hepatotoxicity. Safer antiretroviral therapy regimens are needed in women of childbearing age.

Elisabetta Xue and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1350–1357, https://doi.org/10.1093/cid/ciaa222

Cord blood transplant (CBT) recipients have a high cumulative incidence of herpes zoster (HZ) despite longer-term antiviral prophylaxis. Antiviral prophylaxis during immunosuppression and for 3 or more years might reduce the incidence and complications of HZ after CBT.

Ralf Krumkamp and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1358–1366, https://doi.org/10.1093/cid/ciaa223

A contact network analysis in 4 countries of sub-Saharan Africa revealed Cryptosporidium neighborhood clusters in rural communities with human-to-human transmission being the predominant transmission route, while zoonotic transmission appears to contribute only marginally.

Poonum S Korpe
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1367–1368, https://doi.org/10.1093/cid/ciaa228
Jason A Roberts and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1369–1378, https://doi.org/10.1093/cid/ciaa224

In this multinational study of critically ill patients treated with renal replacement therapy (RRT), antibiotic dosing regimens, RRT prescription, and estimated total renal clearance varied markedly and resulted in highly variable antibiotic concentrations that frequently failed to meet therapeutic targets.

Emmanouil Glampedakis and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1379–1385, https://doi.org/10.1093/cid/ciaa230

Aspergillus group ustus (section Usti) represents a rare cause of invasive aspergillosis (IA). This retrospective multicenter study reports the epidemiology and outcome of 72 cases of proven/probable IA due to this fungal pathogen.

Margarita Semis and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1386–1391, https://doi.org/10.1093/cid/ciaa231

This is the first report of invasive Stachybotrys sinusitis in a severely immunocompromised patient with refractory acute lymphocytic leukemia. Tissue invasion by Stachybotrys chlorohalonata was confirmed by histopathology, IHC, and genotyping. The patient was successfully treated, but later succumbed from other causes.

Evan B Cunningham and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1392–1400, https://doi.org/10.1093/cid/ciaa253

Among this high-risk population, the overall incidence of reinfection was 3.1 cases/100 person-years, considerably lower than the incidence of primary infection among similar populations. The incidence was elevated among younger people and people who shared needles/syringes.

Joshua A Barocas
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1401–1403, https://doi.org/10.1093/cid/ciaa258
Curtis D Collins and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1404–1412, https://doi.org/10.1093/cid/ciaa232

Implementation of an internally developed, cross-reactivity chart for surgical prophylaxis in patients with a documented B-lactam allergy, in combination with enhanced antimicrobial stewardship program, pharmacy, and organizational processes, significantly improved the prescribing of B-lactam antibiotic therapy for surgical prophylaxis.

Tracy R Glass and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1413–1421, https://doi.org/10.1093/cid/ciaa239

People with HIV starting antiretroviral therapy when asymptomatic did as well if not better than symptomatic individuals with respect to adherence and treatment outcomes. This evidence supports differentiated care models focusing resources on vulnerable groups in need of support.

Stephen M Bart and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1422–1428, https://doi.org/10.1093/cid/ciaa246

In antibacterial drug trials for serious bacterial diseases, changes over time in Eastern European and North American enrollment were observed. Subject demographic, clinical, and microbiologic factors were generally similar among regions, supporting the global generalizability of trial results.

Clara Clipet-Jensen and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1429–1436, https://doi.org/10.1093/cid/ciaa291

Diphtheria-tetanus-pertussis (DTP) with or after measles vaccine was associated with two-fold higher mortality than having measles vaccine as last vaccination. DTP after measles vaccine was associated with a strong negative effect for girls, the female-male mortality ratio being 14.83 (1.88-117.1).

Frank Shann
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1437–1439, https://doi.org/10.1093/cid/ciaa292

BRIEF REPORTS

Isabelle Vock and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1440–1443, https://doi.org/10.1093/cid/ciaa895
Rohma Ghani and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1444–1447, https://doi.org/10.1093/cid/ciaa948
Sahil Khanna
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1448–1449, https://doi.org/10.1093/cid/ciaa943
Christopher J Lehmann and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1450–1452, https://doi.org/10.1093/cid/ciaa902
Robert Cohen and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1453–1456, https://doi.org/10.1093/cid/ciaa917

VIEWPOINTS

Timothy C Jenkins and Pranita D Tamma
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1457–1462, https://doi.org/10.1093/cid/ciaa1003

We discuss a framework of interventions and policies aimed at engaging and equipping frontline clinicians to optimize their antibiotic use to reduce the need for day-to-day antibiotic stewardship program oversight.

Jaspreet Toor and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1463–1466, https://doi.org/10.1093/cid/ciaa933

The COVID-19 pandemic has disrupted neglected tropical disease programs. Modelling shows the impact of this will vary across diseases. Once interventions are reintroduced, there are opportunities for mitigating the delay and accelerating progress towards the 2030 goals.

REVIEW ARTICLE

Chanu Rhee and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1467–1474, https://doi.org/10.1093/cid/ciaa1249

This review summarizes the current evidence regarding the duration of infectivity of SARS-CoV-2 and how this has informed evolving public health recommendations on when it is safe to discontinue isolation precautions.

INVITED ARTICLE

INNOVATIONS IN DESIGN, EDUCATION AND ANALYSIS (IDEA)

Le Khanh Ngan Nguyen and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1475–1480, https://doi.org/10.1093/cid/ciaa1276

Hybrid simulation for modeling infections is promising, as it can help gain deeper insights, assist decision-making at different management levels, and provide a balance between simulation performance and result accuracy, yet challenging to adopt without comprehensive theoretical and technical guidance.

PHOTO QUIZ

Joan Padrosa and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1481–1483, https://doi.org/10.1093/cid/ciaa1672

CORRESPONDENCE

Maroun M Sfeir
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1484–1485, https://doi.org/10.1093/cid/ciaa878
Johann Motsch and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1485–1486, https://doi.org/10.1093/cid/ciaa881
Ana Fernández-Cruz and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1486–1487, https://doi.org/10.1093/cid/ciaa865
George Alangaden and Mayur S Ramesh
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Page 1487, https://doi.org/10.1093/cid/ciaa870
Sebastian Mang and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1487–1489, https://doi.org/10.1093/cid/ciaa906
Guillermo Aquino-Jarquin
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1489–1490, https://doi.org/10.1093/cid/ciaa830
Fengting Yu and others
Clinical Infectious Diseases, Volume 72, Issue 8, 15 April 2021, Pages 1490–1491, https://doi.org/10.1093/cid/ciaa843
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close